William Blair
The William Blair Thinking Podcast
The William Blair Thinking Podcast aims to provide in-depth expertise on today's financial and economic landscape. William Blair Thinking Podcast features two series:-William Blair Thinking Presents, a new podcast series that dives deep into conversation with our award-winning equity research and capital advisory experts.-Biotech Breakthroughs, a new podcast series from our equity research group that explores the news and trends shaping the biotech industry. For more, go to https://www.williamblair.com/ThinkingCopyright 2026 William Blair & Company. L.L.C. “William Blair” and R Docs are regist...
Be sure to visit the podcast's website and support the creator: www.williamblair.com
Author
William Blair
Category
Podcast website
Latest episode
Nov 3, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Biotech Breakthroughs - The Revolutionary Potential of Cell Therapy for Autoimmune Disorders 11.01.2024 22:22
Clinical case studies have sparked significant interest in the use of CAR-T for autoimmune disorders, potentially expanding CAR-Ts’ utility beyond oncology. In this podcast episode of Biotech Breakthroughs, equity research analyst Sami Corwin offers an overview of the known biological underpinnings of autoimmunity and rationale for using CAR-T as a therapeutic, breaks down the CAR-T cell therapy c...
Monthly Macro 2024 Outlook 15.12.2023 27:50
Macro analyst Richard de Chazal reflects on the resilient year and expands on his 2024 Outlook’s key themes, including the sticky pockets of inflation, the 3 keys the Fed needs to achieve success next year, Treasury Secretary Yellen’s “Operation Twist” reboot, and more. *Recorded December 8, 2023
On The Ground and In The Cloud: A Deep Dive Into the Trends Impacting Developer Technologies 01.12.2023 25:45
Software developers not only represent the early adopters who will determine the success of a particular product or project, but also have become primary influencers in software purchases. In this episode, analysts Jason Ader, Arjun Bhatia, and Jonathan Ho delve into the key trends and potential disruptions, including generative AI, in this exciting new era of coding capabilities.
Monthly Macro with Richard de Chazal (October 2023) 21.11.2023 30:17
Macro analyst Richard de Chazal breaks down what he believes are the three hurdles to 'higher for longer,' walks through what third quarter earnings may say about the near term future and offers his stance on where the Fed is potentially headed as we move towards a new year. *Recorded November 8, 2023
Biotech Breakthroughs - Exploring the Recent Radiopharmaceutical Renaissance 06.11.2023 32:14
Radiopharmaceuticals are leading the way in how oncology patients are being diagnosed and treated. In this episode of Biotech Breakthroughs, Tim Lugo is joined by equity analyst Andy Hsieh and equity research associate Alex Ramsey to examine why radioisotope innovation may revolutionize treatment for millions of people in the coming years.
Monthly Macro with Richard de Chazal (Sept 2023) 16.10.2023 25:14
Housing, retail sales, and the Sahm Rule. Hear what macro analyst Richard de Chazal outlines in this latest Monthly Macro podcast, and what’s in store for the markets as we near a critical FOMC meeting next month.
Biotech Breakthroughs - Advancing Diabetes Treatments: Exploring GLP-1s and Beyond 13.10.2023 28:34
Tim Lugo speaks with fellow equity research analysts Margaret Kaczor Andrew and Andy Hsieh about the GLP-1 drug class and its impact on the management of obesity, including potential read-throughs to the medtech and the therapeutics sector.
Biotech Breakthroughs - Putting the Tech in Biotech: A Deep Dive on AI in the Sector 28.09.2023 25:54
Biotech equity research group head Tim Lugo explores the impact of artificial intelligence and machine learning on the biotechnology industry, including the ways in which AI is revolutionizing drug development, impacting valuations, and the potential risks that lie ahead.
The Coming Healthcare Cost Tsunami 16.09.2023 21:59
Healthcare equity research group head Ryan Daniels walks through his team’s recent report, the 'Coming Healthcare Cost Tsunami,’ to discuss how employers are leveraging partners to drive greater health and benefit satisfaction among employees and contain healthcare costs more effectively.
Monthly Macro with Richard de Chazal (August 2023) 08.09.2023 29:49
William Blair macro analyst Richard de Chazal discusses Fitch’s U.S. government debt downgrade, the resilience of the American consumer, inflation insights, yield curve dynamics, and the global economic puzzle. *Episode recorded August 22, 2023
Artificial Intelligence in Information Services: Evaluating the Ramifications of a New AI Paradigm 01.09.2023 21:59
William Blair global services analyst Andrew Nicholas examines the industry-wide impacts, implications, and potential risks that artificial intelligence presents for the information services sector, and offers an overview of the framework he employs to evaluate information services companies in light of these industry-wide dynamics.
Residential Services: A Key Growth Industry for the Next Decade 09.08.2023 26:33
William Blair global services analyst Tim Mulrooney shares insights from his residential services report, in which he outlines the various markets poised for growth, such as pest control, HVAC, lawn care, pool services, and more. Tim also sheds light on several megatrends that are reshaping these markets and should catch the attention of investors.
Monthly Macro with Richard de Chazal (July 2023) 04.08.2023 27:21
William Blair macro analyst Richard de Chazal discusses key economic indicators, the elusive “r-star” interest rate, trends in the housing market, the inflation outlook, and the market’s “fear of missing out” sentiment. *Episode was recorded on July 20, 2023.
Addressing Social Determinants of Health Through Food-as-Medicine 19.07.2023 22:42
William Blair healthcare analyst Ryan Daniels dives into his quarterly Healthcare Mosaic report, which focuses on “food as medicine,” an emerging area in addressing social determinants of health. Ryan covers the market and regulatory-driven trends driving growth in the food-as-medicine movement across the United States, details the types of food-as-medicine interventions in the market today, expla...
Monthly Macro with Richard de Chazal (June 2023) 11.07.2023 19:55
William Blair macro analyst Richard de Chazal discusses the latest CPI data, the ongoing impact of the Federal Reserve’s inflation fight, and his economic outlook for the near and long-term. Additionally, Richard provides listeners with macro highlights from William Blair's 43rd Annual Growth Stock Conference and shares insights into attending management teams' assessment of the macroeconomic land...
Generative AI: The New Frontier of Automation 06.07.2023 24:44
William Blair equity research analysts Jason Ader, Arjun Bhatia, and Ralph Schackart explore the disruptive, ubiquitous subject of generative AI and its broad implications across the technology sector, the economy, and society. Leveraging their expertise in infrastructure, SaaS, and the consumer internet space, they deliver a comprehensive discussion tailored for those seeking a deeper understandi...
Restaurant Automation: An Idea Whose Time Has Finally Come? 30.05.2023 17:17
In this inaugural episode, William Blair equity research group heads Sharon Zackfia and Larry De Maria discuss how automation and robotics are expected to have a significant impact on the restaurant industry by increasing efficiency, consistency, and profitability.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.